| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.27B | 2.49B | 2.12B | 1.81B | 2.04B |
| Gross Profit | 487.73M | 365.67M | 340.56M | 289.44M | 257.13M |
| EBITDA | 205.86M | 191.45M | 201.00M | 189.48M | 153.65M |
| Net Income | 133.13M | 127.12M | 120.47M | 96.02M | 66.69M |
Balance Sheet | |||||
| Total Assets | 2.04B | 2.00B | 1.76B | 1.53B | 1.21B |
| Cash, Cash Equivalents and Short-Term Investments | 742.36M | 562.53M | 566.53M | 457.77M | 186.03M |
| Total Debt | 20.59M | 909.00K | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.15B | 1.20B | 1.03B | 872.50M | 641.22M |
| Stockholders Equity | 881.37M | 803.16M | 730.21M | 653.16M | 572.83M |
Cash Flow | |||||
| Free Cash Flow | 235.23M | 275.42M | 142.78M | 293.39M | 131.83M |
| Operating Cash Flow | 325.52M | 376.94M | 279.80M | 399.39M | 252.12M |
| Investing Cash Flow | -84.39M | -320.07M | -120.73M | -103.25M | -120.10M |
| Financing Cash Flow | -61.30M | -60.88M | -50.30M | -24.39M | -26.58M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$2.20B | 3.90 | 16.17% | 12.15% | -3.66% | 4.32% | |
73 Outperform | HK$427.50M | 1.85 | 15.79% | 5.71% | -8.56% | 4.84% | |
73 Outperform | HK$1.18B | 17.58 | 5.24% | 13.24% | -13.83% | 50.41% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | HK$1.26B | 1,251.38 | -0.11% | ― | -2.02% | -101.97% | |
49 Neutral | HK$1.28B | -13.79 | -101.13% | ― | 12.98% | 19.18% | |
46 Neutral | HK$300.46M | -0.25 | -11.32% | ― | -8.54% | -25.17% |